These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24736382)

  • 1. Altered interactions between cardiac myosin binding protein-C and α-cardiac actin variants associated with cardiomyopathies.
    Chow ML; Shaffer JF; Harris SP; Dawson JF
    Arch Biochem Biophys; 2014 May; 550-551():28-32. PubMed ID: 24736382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac actin changes in the actomyosin interface have different effects on myosin duty ratio.
    Liu H; Henein M; Anillo M; Dawson JF
    Biochem Cell Biol; 2018 Feb; 96(1):26-31. PubMed ID: 28972856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.
    Müller M; Mazur AJ; Behrmann E; Diensthuber RP; Radke MB; Qu Z; Littwitz C; Raunser S; Schoenenberger CA; Manstein DJ; Mannherz HG
    Cell Mol Life Sci; 2012 Oct; 69(20):3457-79. PubMed ID: 22643837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations.
    Wong FL; Bunch TA; Lepak VC; Steedman AL; Colson BA
    J Mol Cell Cardiol; 2024 Jan; 186():125-137. PubMed ID: 38008210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between cardiac myosin-binding protein C and formin Fhod3.
    Matsuyama S; Kage Y; Fujimoto N; Ushijima T; Tsuruda T; Kitamura K; Shiose A; Asada Y; Sumimoto H; Takeya R
    Proc Natl Acad Sci U S A; 2018 May; 115(19):E4386-E4395. PubMed ID: 29686099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutations in the tri-helix bundle of the M-domain of cardiac myosin binding protein-C influence systolic duration and delay cardiac relaxation.
    van Dijk SJ; Kooiker KB; Napierski NC; Touma KD; Mazzalupo S; Harris SP
    J Mol Cell Cardiol; 2018 Jun; 119():116-124. PubMed ID: 29729251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position.
    Mun JY; Kensler RW; Harris SP; Craig R
    J Mol Cell Cardiol; 2016 Feb; 91():141-7. PubMed ID: 26718724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cardiac myosin-binding protein C restricts actin structural dynamics in a cooperative and phosphorylation-sensitive manner.
    Bunch TA; Kanassatega RS; Lepak VC; Colson BA
    J Biol Chem; 2019 Nov; 294(44):16228-16240. PubMed ID: 31519753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The W792R HCM missense mutation in the C6 domain of cardiac myosin binding protein-C increases contractility in neonatal mouse myocardium.
    Mertens J; De Lange WJ; Farrell ET; Harbaugh EC; Gauchan A; Fitzsimons DP; Moss RL; Ralphe JC
    J Mol Cell Cardiol; 2024 Oct; 195():14-23. PubMed ID: 39059462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation.
    Harris SP; Belknap B; Van Sciver RE; White HD; Galkin VE
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1558-63. PubMed ID: 26831109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner.
    Shaffer JF; Kensler RW; Harris SP
    J Biol Chem; 2009 May; 284(18):12318-27. PubMed ID: 19269976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.
    Sommese RF; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM
    PLoS One; 2013; 8(12):e83403. PubMed ID: 24367593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Terminal Fragment of Cardiac Myosin Binding Protein-C Increases the Duration of Actin-Myosin Interaction.
    Nabiev SR; Kochurova AM; Nikitina LV; Beldiia EA; Matyushenko AM; Yampolskaya DS; Bershitsky SY; Kopylova GV; Shchepkin DV
    Bull Exp Biol Med; 2024 Jan; 176(3):324-327. PubMed ID: 38336971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subdomain location of mutations in cardiac actin correlate with type of functional change.
    Mundia MM; Demers RW; Chow ML; Perieteanu AA; Dawson JF
    PLoS One; 2012; 7(5):e36821. PubMed ID: 22590617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The A31P missense mutation in cardiac myosin binding protein C alters protein structure but does not cause haploinsufficiency.
    van Dijk SJ; Bezold Kooiker K; Mazzalupo S; Yang Y; Kostyukova AS; Mustacich DJ; Hoye ER; Stern JA; Kittleson MD; Harris SP
    Arch Biochem Biophys; 2016 Jul; 601():133-40. PubMed ID: 26777460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
    Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
    Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using baculovirus/insect cell expressed recombinant actin to study the molecular pathogenesis of HCM caused by actin mutation A331P.
    Bai F; Caster HM; Rubenstein PA; Dawson JF; Kawai M
    J Mol Cell Cardiol; 2014 Sep; 74():64-75. PubMed ID: 24793351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of thin filament activation of myosin ATP hydrolysis by N-terminal domains of cardiac myosin binding protein-C.
    Belknap B; Harris SP; White HD
    Biochemistry; 2014 Oct; 53(42):6717-24. PubMed ID: 25265574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.